Letter by Donzelli et al Regarding Article, "Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)"

Circulation. 2018 Oct 23;138(17):1912-1913. doi: 10.1161/CIRCULATIONAHA.118.034068.

¹ Unit of Appropriateness in Primary Care, Health Protection Agency, Milan, Italy (A.D.).
² Public Health and Preventive Medicine, University of Milano-Bicocca, Milan, Italy (A.S., G.G.).

No abstract available

Publication types